The stock of Constellation Healthcare Tech Inc (LON:CHT) gapped down by GBX 1.5 today and has GBX 166.50 target or 10.00% below today’s GBX 185.00 share price. The 8 months technical chart setup indicates high risk for the GBX 168.01M company. The gap down was reported on Nov, 18 by Barchart.com. If the GBX 166.50 price target is reached, the company will be worth GBX 16.80 million less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. The stock decreased 0.27% or GBX 0.5 on November 18, hitting GBX 185. About 6,356 shares traded hands. Constellation Healthcare Tech Inc (LON:CHT) has risen 28.37% since April 20, 2016 and is uptrending. It has outperformed by 23.94% the S&P500.
Another recent and important Constellation Healthcare Tech Inc (LON:CHT) news was published by Themiddlemarket.com which published an article titled: “Leads for New M&A Rose in February, but the Tally for Closed Deals Kept Falling” on March 05, 2016.
Constellation Healthcare Technologies, Inc. is a healthcare services organization providing outsourced business services to the physician market. The company has a market cap of 168.01 million GBP. The Firm operates through three operating divisions: Revenue Cycle Management , Practice Management (PM) and Group Purchasing Organization (GPO). It has a 12.66 P/E ratio. The RCM segment offers medical billing and collections, practice management, and other related services to hospital and office physicians, allowing them to focus on patient care in specialties, such as pathology, anesthesiology, radiology, cardiology, family practice, internal medicine, orthopedics, neurology and emergency medicine.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.